Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avastin plus Bortezomib in Recurrent Malignant Glioma
NCT00611325Phase 2Completed
- Sponsor
- Duke University
- Start
- May 2008
- Primary completion
- Sep 2009
- Modality
- Small Molecules, Modified Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of bortezomib in glioblastoma (GBM), Gliosarcoma (GS), sponsored by Duke University. Started May 2008; status: completed.
02
Drugs
bortezomib
03
Conditions
glioblastoma (GBM)Gliosarcoma (GS)
Beyond the preview
Go deeper on NCT00611325.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00611325.